Importantly, the anti-DNA− SLE patients revealed no significant correlation between the frequency of CCR6+ Th cell subsets and any disease indicator (P > 0.05; Fig. 5 and Fig. S1). This evidence concerns the gene CCR6 and systemic lupus erythematosus.